The Impact of Drug Resistance on the Effectiveness of Chemotherapy for Chronic Hepatitis B
- 1 October 2000
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 32 (4), 866-867
- https://doi.org/10.1053/jhep.2000.18194
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Long-Term Therapy of Chronic Hepatitis B With LamivudineHepatology, 2000
- Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patientsHepatology, 1999
- Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immuLiver Transplantation and Surgery, 1999
- Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under hbig immunoglobulin after liver transplantationHepatology, 1999
- Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapyHepatology, 1999
- Multicenter study of lamivudine therapy for hepatitis B after liver transplantationHepatology, 1999
- Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.JCI Insight, 1998
- Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapyHepatology, 1998
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- A Controlled Trial Comparing Foscarnet with Vidarabine for Acyclovir-Resistant Mucocutaneous Herpes Simplex in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991